SCOPUS 정보 검색 플랫폼

Volumn 91, Issue 3, 2012, Pages 385-387

Heterotropic effects on drug-metabolizing enzyme activities: In vitro curiosity emerges as a clinically meaningful phenomenon (perhaps?)

(1) Obach, R S a

a PFIZER INC (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYMIDAZOLAM; ALPHA HYDROXYMIDAZOLAM; CARBAMAZEPINE; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; DESLORATADINE; DEXNORFENFLURAMINE; DICLOFENAC; DRUG METABOLITE; DRUG METABOLIZING ENZYME; ENDOXIFEN; FELBAMATE; FLUCONAZOLE; GEMFIBROZIL; GEMFIBROZIL GLUCURONIDE; GLUCURONIDE; MIDAZOLAM; NORFLUOXETINE; QUINIDINE; UNCLASSIFIED DRUG;

DRUG CLEARANCE; DRUG GLUCURONIDATION; DRUG HYDROXYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; REVIEW;

CYTOCHROME P-450 CYP3A; FLUCONAZOLE; HUMANS; MIDAZOLAM;

EID: 84857204051 PISSN: 00099236 EISSN: 15326535 Source Type: Journal
DOI: 10.1038/clpt.2011.182 Document Type: Review

Times cited : (6)

References (10)

1
- 84857197083
- Evidence of CYP3A allosterism in vivo: Analysis of interaction between fluconazole and midazolam
- Yang, J., Atkins, W.M., Isoherranen, N., Paine, M.F. & Thummel, K.E. Evidence of CYP3A allosterism in vivo: analysis of interaction between fluconazole and midazolam. Clin. Pharmacol. Ther. 91, 442-449 (2012).
- (2012) Clin. Pharmacol. Ther. , vol.91 , pp. 442-449
- Yang, J.¹ Atkins, W.M.² Isoherranen, N.³ Paine, M.F.⁴ Thummel, K.E.⁵

2
- 47749131934
- Heterotropic cooperativity in oxidation mediated by cytochrome P450
- DOI 10.2174/138920008784746364
- Niwa, T., Murayama, N. & Yamazaki, H. Heterotropic cooperativity in oxidation mediated by cytochrome P450. Curr. Drug Metab. 9, 453-462 (2008). (Pubitemid 352025198)
- (2008) Current Drug Metabolism , vol.9 , Issue.5 , pp. 453-462
- Niwa, T.¹ Murayama, N.² Yamazaki, H.³

3
- 0032735988
- CYP3A4 drug interactions: Correlation of 10 in vitro probe substrates
- DOI 10.1046/j.1365-2125.1999.00073.x
- Kenworthy, K.E., Bloomer, J.C., Clarke, S.E. & Houston, J.B. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. Br. J. Clin. Pharmacol. 48, 716-727 (1999). (Pubitemid 29520596)
- (1999) British Journal of Clinical Pharmacology , vol.48 , Issue.5 , pp. 716-727
- Kenworthy, K.E.¹ Bloomer, J.C.² Clarke, S.E.³ Houston, J.B.⁴

4
- 29244447987
- The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions
- DOI 10.1124/jpet.105.093229
- Obach, R.S. et al. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions. J. Pharmacol. Exp. Ther. 316, 336-348 (2006). (Pubitemid 41832613)
- (2006) Journal of Pharmacology and Experimental Therapeutics , vol.316 , Issue.1 , pp. 336-348
- Obach, R.S.¹ Walsky, R.L.² Venkatakrishnan, K.³ Gaman, E.A.⁴ Houston, J.B.⁵ Tremaine, L.M.⁶

5
- 10744232330
- The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
- DOI 10.1124/dmd.31.7.815
- Bjornsson, T.D. et al. The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical ResearcHand Manufacturers of America (PhRMA) perspective. Drug Metab. Dispos. 31, 815-832 (2003). (Pubitemid 36759050)
- (2003) Drug Metabolism and Disposition , vol.31 , Issue.7 , pp. 815-832
- Bjornsson, T.D.¹ Callaghan, J.T.² Einolf, H.J.³ Fischer, V.⁴ Gan, L.⁵ Grimm, S.⁶ Kao, J.⁷ King, S.P.⁸ Miwa, G.⁹ Ni, L.¹⁰ Kumar, G.¹¹ McLeod, J.¹² Obach, R.S.¹³ Roberts, S.¹⁴ Roe, A.¹⁵ Shah, A.¹⁶ Snikeris, F.¹⁷ Sullivan, J.T.¹⁸ Tweedie, D.¹⁹ Vega, J.M.²⁰ Walsh, J.²¹ Wrighton, S.A.²² more..

6
- 33846448814
- US Food and Drug Administration. Draft guidance September
- US Food and Drug Administration. Guidance for Industry: Drug Interaction Studies-Study Design, Data Analysis, and Implications for Dosing and Labeling. Draft guidance 〈http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm072101.pdf〉 (September 2006).
- (2006) Guidance for Industry: Drug Interaction Studies-Study Design Data Analysis and Implications for Dosing and Labeling

7
- 4644301430
- The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-Å resolution
- DOI 10.1074/jbc.C400293200
- Yano, J.K. et al. The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05 Å resolution. J. Biol. Chem. 279, 38091-38094 (2004). (Pubitemid 39295952)
- (2004) Journal of Biological Chemistry , vol.279 , Issue.37 , pp. 38091-38094
- Yano, J.K.¹ Wester, M.R.² Schoch, G.A.³ Griffin, K.J.⁴ Stout, C.D.⁵ Johnson, E.F.⁶

8
- 3442896773
- Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone
- DOI 10.1126/science.1099736
- Williams, P.A. et al. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science 305, 683-686 (2004). (Pubitemid 39006760)
- (2004) Science , vol.305 , Issue.5684 , pp. 683-686
- Williams, P.A.¹ Cosme, J.² Matak Vinkovic, D.³ Ward, A.⁴ Angove, H.C.⁵ Day, P.J.⁶ Vonrhein, C.⁷ Tickle, I.J.⁸ Jhoti, H.⁹

9
- 0032732349
- Interaction of diclofenac and quinidine in monkeys: Stimulation of diclofenac metabolism
- Tang, W. et al. Interaction of diclofenac and quinidine in monkeys: stimulation of diclofenac metabolism. J. Pharmacol. Exp.Ther. 291, 1068-1074 (1999).
- (1999) J. Pharmacol. Exp.Ther. , vol.291 , pp. 1068-1074
- Tang, W.¹

10
- 0037799740
- In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine
- DOI 10.1124/jpet.102.047530
- Egnell, A.C., Houston, B. & Boyer, S. In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine. J. Pharmacol. Exp. Ther. 305, 1251-1262 (2003). (Pubitemid 36618005)
- (2003) Journal of Pharmacology and Experimental Therapeutics , vol.305 , Issue.3 , pp. 1251-1262
- Egnell, A.-C.¹ Houston, B.² Boyer, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.